Ray Co

Ray Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Ray Co (228670.KQ) as of Nov 18, 2026 is 409.50 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was -0.34 % — a change of -121,093.24% (higher).

Cash Conversion

409.50 %

YoY

-121,093.24%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Ray Co is 2025 409.50 % . Cash Conversion Rate (OCF/Net Income) of Ray Co was 2024 -0.34 % . It decreases by -121,093.24% higher compared to the previous year.

The Ray Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
81.84 KRW
Jan 1, 2019
52.27 KRW
Jan 1, 2020
36.73 KRW
Jan 1, 2021
-87,525.31 KRW
Jan 1, 2022
-103.45 KRW
Jan 1, 2023
1,061.85 KRW
Jan 1, 2024
-0.34 KRW
Jan 1, 2025
409.50 KRW
The Ray Co Cash Conversion history
YEARCash ConversionYoY
409.50 %-121,093.24%
-0.34 %-100.03%
1,061.85 %-1,126.46%
-103.45 %-99.88%
-87,525.31 %-238,366.79%
36.73 %-29.72%
52.27 %-36.14%
81.84 %-14.23%
95.42 %+180.85%
33.98 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Cash Conversion Rate (OCF/Net Income) of Ray Co is 409.50 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Ray Co changed from -0.34 % to 409.50 %, representing a -121,093.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Ray Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Ray Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ray Co

All Key Metrics — Ray Co